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Abstract 
Objective 
To evaluate the features and risk factors associated 
with recrudescent infections that arose following 
artemisinin-based combination drug treatment of the 
primary infections. 
Methods 
The clinical features and risk factors associated with 
subsequent recrudescence of primary Plasmodium 
falciparum infections were evaluated in 37 of 877 
children following artesunate or artemisinin-based 
combination treatments (ACTs). Recrudescence was 
determined by polymerase chain reaction. 
Results 
Compared to children with sensitive infections, 
children with recrudescent infections had 
significantly higher gametocytaemia and proportion 
with parasitaemia >50 000/μL. Compared with 
primary infections, recrudescent infections that arose 
from primary infections were accompanied by 
significantly fewer symptoms, lower body 
temperatures and asexual parasitaemias. In age- and 
gender-matched children with and without 
recrudescence, declines in parasitaemias following 
treatment were monoexponential but elimination 
half-life of parasitaemia was significantly longer in 
children with recrudescence. In a multiple regression 
model, at enrolment, 3 factors were independent risk 
factors for subsequent recrudescence of primary 
infections: parasitaemia ⩾50 000/μL [adjusted odds 
ratio (AOR)=2.63, 95% confidence interval (CI): 
1.17-5.90, P=0.018], parasite clearance time ⩾2 
days (AOR=2.47, 95% CI: 1.24-4.90, P=0.04) and 
treatment with artesunate compared with ACTs 
(AOR=2.35, 95% CI: 1.08-5.12, P=0.03). 
Conclusions 
Recrudescent infections following artesunate or 
ACTs differ significantly from the primary 
infections from which they arose and have 
implications for malaria control efforts in Sub-
Saharan Africa where ACTs are now first-line 
treatments. 
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